Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the history list. The notice about government funding operating status and the earlier revision v3.4.1 were removed.SummaryDifference0.3%

- Check20 days agoChange DetectedAdministrative updates were added to the history: a new notice about funding and a new version marker (v3.4.1) replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedThe history view now includes a Show glossary option and explanations for the color-coded changes (green = additions, red = deletions) and for data change color coding. Revision metadata now shows Revision: v3.4.0 and the No FEAR Act data label and the Revision: v3.3.4 text were removed.SummaryDifference0.3%

- Check35 days agoChange DetectedMultiple historical- and navigation-related UI elements were removed from the study record page, including Record History, Study Record Versions, Results Posted, Researcher View, Study Details, Save, and Download options, as well as related date/version listings. The core study information remains visible, but access to version history and downloadable results is no longer available from this view.SummaryDifference17%

- Check42 days agoChange DetectedThe page history now lists a new revision (v3.3.4) and removes the previous revision (v3.3.3).SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a new revision entry v3.3.3 to the Record History and removed the HHS Vulnerability Disclosure and revision v3.3.2.SummaryDifference0.1%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.